3,091 Shares in Kenvue Inc. (NYSE:KVUE) Purchased by Brooklyn Investment Group

Brooklyn Investment Group acquired a new position in Kenvue Inc. (NYSE:KVUE) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 3,091 shares of the company’s stock, valued at approximately $71,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Advisors Asset Management Inc. purchased a new stake in shares of Kenvue during the first quarter valued at approximately $206,000. Janus Henderson Group PLC increased its holdings in Kenvue by 53.7% in the 1st quarter. Janus Henderson Group PLC now owns 165,162 shares of the company’s stock worth $3,541,000 after acquiring an additional 57,679 shares in the last quarter. Tidal Investments LLC raised its stake in Kenvue by 47.5% during the 1st quarter. Tidal Investments LLC now owns 131,764 shares of the company’s stock worth $2,828,000 after acquiring an additional 42,418 shares during the period. LRI Investments LLC purchased a new position in Kenvue during the first quarter valued at approximately $106,000. Finally, Swedbank AB bought a new position in shares of Kenvue in the first quarter worth approximately $27,856,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

KVUE has been the topic of several recent analyst reports. Bank of America raised their price objective on shares of Kenvue from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Tuesday, October 22nd. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Kenvue from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Wednesday, August 7th. Royal Bank of Canada downgraded shares of Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 price objective on the stock. in a research report on Tuesday, September 24th. Piper Sandler lifted their price target on shares of Kenvue from $20.00 to $21.00 and gave the company a “neutral” rating in a report on Monday, September 23rd. Finally, JPMorgan Chase & Co. lifted their price target on shares of Kenvue from $24.00 to $25.00 and gave the company an “overweight” rating in a report on Friday, October 11th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $22.64.

Kenvue Price Performance

Shares of KVUE opened at $24.13 on Friday. The company has a 50 day moving average price of $22.92 and a 200-day moving average price of $20.96. Kenvue Inc. has a fifty-two week low of $17.67 and a fifty-two week high of $24.46. The stock has a market capitalization of $46.26 billion, a PE ratio of 43.87, a PEG ratio of 2.20 and a beta of 1.36. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.28 EPS for the quarter, topping the consensus estimate of $0.27 by $0.01. Kenvue had a net margin of 6.88% and a return on equity of 21.43%. The firm had revenue of $3.90 billion during the quarter, compared to analyst estimates of $3.92 billion. During the same quarter in the previous year, the business posted $0.31 EPS. Kenvue’s revenue was down .4% on a year-over-year basis. Equities analysts predict that Kenvue Inc. will post 1.07 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, November 27th. Stockholders of record on Wednesday, November 13th were issued a $0.205 dividend. This represents a $0.82 annualized dividend and a dividend yield of 3.40%. The ex-dividend date was Wednesday, November 13th. Kenvue’s dividend payout ratio (DPR) is currently 149.09%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.